Regeneron Pharmaceuticals (REGN)

Total Current Assets

$18.45B

Quarterly · Period ending: · USD

REGN logo

REGN Total Current Assets

Latest reported$18.45B
REGN Quarterly Current Assets ($22.40M → $18.45B)
High-resolution chart · PNG

REGN total current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Total Current Assets — Quarterly (USD)
Period endingTotal Current Assets (USD)
18,446,000,000
18,209,200,000
18,021,900,000
17,980,700,000
16,859,500,000
17,571,700,000
18,660,900,000
19,333,600,000
19,081,600,000
18,871,500,000
19,479,200,000
18,634,800,000
16,923,000,000
16,909,200,000
15,884,100,000
15,428,600,000
15,529,900,000
14,306,000,000
14,014,900,000
13,775,400,000
13,337,600,000
10,055,100,000
9,779,100,000
9,097,600,000
7,860,200,000
8,644,100,000
7,689,100,000
7,109,100,000
6,651,000,000
6,928,600,000
7,959,300,000
5,719,583,000
6,696,021,000
4,544,732,000
5,596,552,000
4,135,742,000
3,860,051,000
3,669,263,000
3,913,920,000
3,501,689,000
3,209,225,000
3,133,379,000
3,383,756,000
2,675,640,000
2,283,341,000
2,310,714,000
2,506,894,000
2,200,512,000
1,918,695,000
1,871,049,000
2,252,208,000
1,634,160,000
1,561,362,000
1,307,122,000
1,620,787,000
948,603,000
769,193,000
696,915,000
652,875,000
339,872,000
413,273,000
695,738,000
720,051,000
575,719,000
417,750,000
395,444,000
425,508,000
461,594,000
526,409,000
483,791,000
521,442,000
715,540,000
742,393,000
787,505,000
797,829,000
422,020,000
496,981,000
489,163,000
469,984,000
273,749,000
291,056,000
319,647,000
341,392,000
324,958,000
359,312,000
369,854,000
343,955,000
311,238,000
383,330,000
392,284,000
320,207,000
404,378,000
295,150,000
329,740,000
276,948,000
313,823,000
309,705,000
337,118,000
394,186,000
252,727,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.